Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Free Tissue Flaps | 4 | 2022 | 372 | 1.850 |
Why?
|
| Perforator Flap | 2 | 2022 | 93 | 1.290 |
Why?
|
| Metacarpal Bones | 1 | 2022 | 2 | 0.880 |
Why?
|
| Arteriovenous Malformations | 1 | 2022 | 70 | 0.840 |
Why?
|
| Soft Tissue Injuries | 1 | 2022 | 51 | 0.830 |
Why?
|
| Wounds, Gunshot | 1 | 2022 | 102 | 0.800 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 551 | 0.610 |
Why?
|
| Rhytidoplasty | 2 | 2015 | 71 | 0.550 |
Why?
|
| Postoperative Complications | 5 | 2022 | 5542 | 0.470 |
Why?
|
| Sacrum | 1 | 2014 | 132 | 0.460 |
Why?
|
| Hematoma | 1 | 2014 | 160 | 0.440 |
Why?
|
| Surgical Flaps | 3 | 2021 | 927 | 0.420 |
Why?
|
| Licensure, Medical | 2 | 2022 | 25 | 0.400 |
Why?
|
| Mediastinal Diseases | 1 | 2011 | 56 | 0.400 |
Why?
|
| Surgery, Plastic | 3 | 2022 | 344 | 0.390 |
Why?
|
| Lymphatic Diseases | 1 | 2011 | 128 | 0.390 |
Why?
|
| Arteries | 2 | 2022 | 274 | 0.380 |
Why?
|
| Head and Neck Neoplasms | 3 | 2021 | 3976 | 0.350 |
Why?
|
| Mammaplasty | 1 | 2017 | 780 | 0.340 |
Why?
|
| Blood Pressure | 1 | 2014 | 1467 | 0.320 |
Why?
|
| Breast Implants | 1 | 2011 | 391 | 0.280 |
Why?
|
| Clavicle | 1 | 2022 | 65 | 0.220 |
Why?
|
| Bone Transplantation | 1 | 2022 | 134 | 0.210 |
Why?
|
| Facial Nerve Injuries | 1 | 2021 | 13 | 0.210 |
Why?
|
| Surgical Wound | 1 | 2022 | 48 | 0.200 |
Why?
|
| Fibula | 1 | 2022 | 146 | 0.200 |
Why?
|
| Private Practice | 1 | 2021 | 31 | 0.200 |
Why?
|
| Hand | 1 | 2022 | 170 | 0.200 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2576 | 0.200 |
Why?
|
| Fee-for-Service Plans | 1 | 2021 | 40 | 0.200 |
Why?
|
| Job Application | 1 | 2020 | 19 | 0.190 |
Why?
|
| Hemangioma | 1 | 2022 | 154 | 0.190 |
Why?
|
| Face | 2 | 2021 | 273 | 0.180 |
Why?
|
| Internship and Residency | 2 | 2022 | 1375 | 0.180 |
Why?
|
| Thigh | 2 | 2021 | 172 | 0.180 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 107 | 0.180 |
Why?
|
| Lower Extremity | 1 | 2022 | 299 | 0.180 |
Why?
|
| Burns | 1 | 2020 | 117 | 0.180 |
Why?
|
| Educational Measurement | 1 | 2022 | 362 | 0.170 |
Why?
|
| Skin Transplantation | 1 | 2020 | 173 | 0.170 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 147 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2022 | 32848 | 0.160 |
Why?
|
| Veins | 1 | 2018 | 157 | 0.150 |
Why?
|
| Neck Dissection | 1 | 2018 | 290 | 0.150 |
Why?
|
| Transplant Donor Site | 1 | 2017 | 11 | 0.150 |
Why?
|
| Reoperation | 2 | 2019 | 1382 | 0.150 |
Why?
|
| Skull | 1 | 2019 | 231 | 0.150 |
Why?
|
| Anatomic Landmarks | 1 | 2017 | 50 | 0.150 |
Why?
|
| Adult | 6 | 2022 | 77950 | 0.150 |
Why?
|
| Humans | 19 | 2022 | 261506 | 0.140 |
Why?
|
| Superficial Musculoaponeurotic System | 1 | 2015 | 5 | 0.140 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 671 | 0.130 |
Why?
|
| Femoral Artery | 1 | 2017 | 210 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 234 | 0.130 |
Why?
|
| Allografts | 1 | 2017 | 650 | 0.130 |
Why?
|
| Graft Survival | 1 | 2018 | 1062 | 0.130 |
Why?
|
| Microsurgery | 1 | 2017 | 244 | 0.120 |
Why?
|
| Minnesota | 1 | 2014 | 93 | 0.120 |
Why?
|
| Surgeons | 1 | 2021 | 519 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2022 | 1270 | 0.120 |
Why?
|
| Molecular Probe Techniques | 2 | 2010 | 46 | 0.110 |
Why?
|
| Middle Aged | 7 | 2022 | 86204 | 0.100 |
Why?
|
| Rupture, Spontaneous | 1 | 2011 | 70 | 0.100 |
Why?
|
| Silicones | 1 | 2011 | 54 | 0.100 |
Why?
|
| Female | 12 | 2022 | 141928 | 0.100 |
Why?
|
| Salvage Therapy | 1 | 2018 | 2054 | 0.090 |
Why?
|
| Aged | 4 | 2018 | 70117 | 0.090 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 143 | 0.090 |
Why?
|
| Male | 6 | 2022 | 123000 | 0.090 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 152 | 0.090 |
Why?
|
| Risk Factors | 2 | 2018 | 17523 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2022 | 37905 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 769 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2009 | 173 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 4298 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 726 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2010 | 384 | 0.070 |
Why?
|
| Sirolimus | 1 | 2010 | 814 | 0.070 |
Why?
|
| Aorta | 1 | 2009 | 692 | 0.060 |
Why?
|
| Hypertension | 1 | 2014 | 1503 | 0.060 |
Why?
|
| Child | 2 | 2022 | 29154 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 669 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2018 | 12873 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 15694 | 0.050 |
Why?
|
| Forearm | 1 | 2022 | 67 | 0.050 |
Why?
|
| Chlorhexidine | 1 | 2022 | 88 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 1390 | 0.050 |
Why?
|
| Facial Nerve | 1 | 2021 | 64 | 0.050 |
Why?
|
| Academic Performance | 1 | 2020 | 14 | 0.050 |
Why?
|
| Physician Executives | 1 | 2020 | 40 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 7551 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 7222 | 0.050 |
Why?
|
| United States | 3 | 2022 | 15433 | 0.040 |
Why?
|
| Internationality | 1 | 2020 | 208 | 0.040 |
Why?
|
| Maxilla | 1 | 2019 | 84 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 2008 | 2518 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2022 | 450 | 0.040 |
Why?
|
| Cicatrix | 1 | 2020 | 208 | 0.040 |
Why?
|
| Head | 1 | 2019 | 249 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2021 | 674 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2022 | 1529 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 2063 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2020 | 769 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 1259 | 0.030 |
Why?
|
| Young Adult | 2 | 2022 | 21445 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 29902 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 4938 | 0.020 |
Why?
|
| Rats | 2 | 2010 | 6086 | 0.020 |
Why?
|
| Calcium Chloride | 1 | 2010 | 23 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2010 | 57 | 0.020 |
Why?
|
| Genes, APC | 1 | 2010 | 70 | 0.020 |
Why?
|
| Adolescent | 2 | 2022 | 31252 | 0.020 |
Why?
|
| Doxycycline | 1 | 2010 | 178 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 210 | 0.020 |
Why?
|
| Disease Progression | 2 | 2010 | 6682 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 5687 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 256 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 459 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 671 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 2314 | 0.020 |
Why?
|
| Animals | 4 | 2010 | 59536 | 0.020 |
Why?
|
| Mice | 3 | 2010 | 34495 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 1265 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 2292 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 13310 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2010 | 1331 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 1546 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2008 | 4307 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2010 | 5710 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 6009 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 5112 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 2522 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 3890 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 12926 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 14551 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 11965 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 21713 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 15179 | 0.010 |
Why?
|